Groundbreaking gene therapy approaches promise durable protection and treatment for pediatric and infectious diseases. A single injection of adeno-associated virus-vectored broadly neutralizing antibodies at birth confers long-lasting immunity against HIV in primate models, potentially transforming vertical HIV prevention strategies. Gene therapy advances also encompass prime editing techniques targeting rare childhood neurological disorders, with laboratory success in reversing pathogenic mutations, signaling progress toward clinical applications in genetic disease correction.